Canaccord

Listed below are today's top pre-market Upgrades at Benzinga: Canaccord Upgrades Total SA (NYSE: TOT) to Hold: Canaccord went on to say “The past two months have seen little sign of the typical defensiveness from the European integrated oils. We don't think this is too surprising, since 1) the...

Listed below are today's Top pre-market Downgrades at Benzinga: Canaccord Genuity Downgrades Northern Dynasty Minerals (NYSE: NAK) to Hold: Canaccord Genuity notes, "We have adjusted our risk profile for NDM based on market conditions and project permitting challenges. We are decreasing our 12-...

Canaccord has published a research report on Cree (NASDAQ: CREE) after the company announced CFO John Kurtzweil would be stepping down this morning. In the report, Canaccord writes, "This morning Cree announced 6-year CFO John Kurtzweil will be stepping down to pursue an opportunity at much...

Listed below is today's coverage on the initiation of ExactTarget (NYSE: ET) at Benzinga: Canaccord Initiates ExactTarget at Buy, $32 PT: Canaccord said, "Exact Target looks set to harvest the reward of nearly a half decade of accelerated technology development with a growth ramp that should...

According to a research report published this morning, Canaccord has initiated EXACTTARGET (NYSE: ET) with a Buy rating and $32 PT. In the report, Canaccord said, "Exact Target looks set to harvest the reward of nearly a half decade of accelerated technology development with a growth ramp that...

According to a research report published earlier today, Canaccord has increased Nu Skin Enterprises' (NYSE: NUS) PT from $57 to $66. In the report, Canaccord said, "Our thesis remains that Nu Skin is in the midst of a powerful product cycle, coupled with a concerted effort to improve margins that...

Listed below are today's Top Downgrades at Benzinga: Canaccord Downgrades MetroPCS (NYSE: PCS) to Hold: Canaccord commented in the report, "With the report and associated commentary, we now question if the business model will be capable of competing in a market where data has become more...

According to a research report published this morning, Canaccord has downgraded United Therapeutics (NASDAQ: UTHR) from Buy to Hold, and lowered PT from $56 to $44. In the report, Canaccord commented, "While the company continues to be a solid cash-generation story, it faces the following...

According to a research report published this morning, Canaccord has decreased Zynga's (NASDAQ: ZNGA) PT from $15 to $13. In the report, Canaccord said, "Although Zynga's Q1 results beat expectations, we believe bookings from the company's core web-based games may be slowing faster than expected....

According to a research report published this morning, Canaccord has increased Amazon.com's (NASDAQ: AMZN) PT from $210 to $230. In the report, Canaccord said, "Amazon delivered a solid revenue recovery along with very low margin outlook due to distribution spending. We are encouraged by digital...